BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...

Key findings from across the 21 scientific presentations on Alcon products will be presented at the meeting, including the soon-to-launch, first non-diffractive extended depth of focus AcrySof® IQ ...

The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for cataract patients.

Please provide your email address to receive an email when new articles are posted on . The Clareon family of IOLs is now available in the U.S., with an international rollout set to take place ...

RxSight is going through a CEO transition at a critical time for the Aliso Viejo, CA-based op company. Aziz Mottiwala will take the helm July 20 as president and CEO, succeeding Ron Kurtz, MD. Kurtz ...

Please provide your email address to receive an email when new articles are posted on . Alcon is introducing multifocal and multifocal toric ultraviolet-absorbing IOLs to the AcrySof portfolio, as ...

Oppenheimer has upgraded Alcon Inc (NYSE:ALC) following firm first-quarter earnings and several new drivers coming into view. The analyst sees a new opportunity in glaucoma with the announced ...

Narrow-moat Alcon ALC reported second-quarter earnings that were ahead of our expectations. Total sales were up 9.2% year over year as strong performance from both surgical and visioncare units ...

Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%31-34; PanOptix® Trifocal IOL, implanted over 2.2 ...